Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP705711.RAIrqLgMy57gztx8SGz-MvigciN7rR4Avsbhnpar8_nww130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP705711.RAIrqLgMy57gztx8SGz-MvigciN7rR4Avsbhnpar8_nww130_assertion type Assertion NP705711.RAIrqLgMy57gztx8SGz-MvigciN7rR4Avsbhnpar8_nww130_head.
- NP705711.RAIrqLgMy57gztx8SGz-MvigciN7rR4Avsbhnpar8_nww130_assertion description "[Our results suggest that Brenner tumors and TCCs follow different tumorigenic pathways, whereas borderline and malignant Brenner tumors are low-grade neoplasms with activation of the PI3K/AKT pathway through EGFR, TCCs are high-grade tumors that have p53 mutations and p16 and p53 protein overexpression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP705711.RAIrqLgMy57gztx8SGz-MvigciN7rR4Avsbhnpar8_nww130_provenance.
- NP705711.RAIrqLgMy57gztx8SGz-MvigciN7rR4Avsbhnpar8_nww130_assertion evidence source_evidence_literature NP705711.RAIrqLgMy57gztx8SGz-MvigciN7rR4Avsbhnpar8_nww130_provenance.
- NP705711.RAIrqLgMy57gztx8SGz-MvigciN7rR4Avsbhnpar8_nww130_assertion SIO_000772 19033864 NP705711.RAIrqLgMy57gztx8SGz-MvigciN7rR4Avsbhnpar8_nww130_provenance.
- NP705711.RAIrqLgMy57gztx8SGz-MvigciN7rR4Avsbhnpar8_nww130_assertion wasDerivedFrom befree-2016 NP705711.RAIrqLgMy57gztx8SGz-MvigciN7rR4Avsbhnpar8_nww130_provenance.
- NP705711.RAIrqLgMy57gztx8SGz-MvigciN7rR4Avsbhnpar8_nww130_assertion wasGeneratedBy ECO_0000203 NP705711.RAIrqLgMy57gztx8SGz-MvigciN7rR4Avsbhnpar8_nww130_provenance.